Form 4: Artivion Director Reports Estate Planning Share Transfer

Director Anthony B. Semedo transferred 6,325 shares of Artivion common stock to a living trust for estate planning purposes.

Summary

• Director Anthony B. Semedo transferred 6,325 shares of Artivion common stock from his direct ownership to the Stacie Nelson and Anthony Semedo Living Trust.
• The transaction occurred on June 2, 2026, at a price of $0, as it was a non-market transfer for estate planning purposes.
• Following the transaction, the reporting person holds 40,635 shares directly and 6,325 shares indirectly through the trust, in addition to 600 shares held by his spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and does not represent a change in the director's economic interest in the company.

Positives

• The transaction reflects long-term commitment to the company through continued beneficial ownership via a family trust.

Negatives

• None.

Risks

• None.

Future Outlook

Not applicable as this is an administrative filing regarding beneficial ownership.

Industry Context

StockSavvy.ai notes that internal transfers of shares for estate planning purposes are standard corporate governance activities and do not reflect changes in management's outlook on company performance.

Comparison to Industry Standards

• This transaction is consistent with standard executive and director estate planning practices observed across the medical device and biotechnology sectors.

Related Party Transactions

• The reporting person transferred shares to a living trust for which he and his spouse serve as trustees.

Stakeholder Impact

• No material impact on shareholders, employees, or customers.

Next Steps

• None.

Key Dates

Keywords

Artivion, AORT, Insider Trading, Form 4, Estate Planning, Beneficial Ownership